Dubois-Randé J L, Benvenuti C, Pouillart F, Le Besnerais P, Loisance D
Fédération de Cardiologie, Hôpital Henri-Mondor, Créteil.
Chirurgie. 1997 Jan;121(9-10):676-84.
Over the last decade, we have seen considerable progress both in medical treatment of acute and chronic heart failure and in circulatory assist systems, including the first used aorta counter-pulse system. More sophisticated systems have been developed with specific indications recognized by specialized teams. However, in the treatment of chronic heart failure, whether caused by idiopathic dilated cardiomyopathies or ischemic heart disease (frequently improved with coronary revascularization), the nature of the disease in patients hospitalized in intensive care units has greatly changed. There is a net tendency towards hospitalizing older patients who may no longer be reasonable candidates for transplantation. The option of circulatory assist is thus undoubtedly reasonable for these patients due to the lack of a sufficient number of donor organs.
在过去十年中，我们在急慢性心力衰竭的医学治疗以及循环辅助系统方面都取得了显著进展，其中包括首次使用的主动脉反搏系统。更先进的系统已经研发出来，并有专业团队认可的特定适应症。然而，在慢性心力衰竭的治疗中，无论是由特发性扩张型心肌病还是缺血性心脏病引起的（冠状动脉血运重建常常可改善病情），入住重症监护病房的患者的疾病性质已经发生了很大变化。目前有一种总体趋势，即收治那些可能不再适合移植的老年患者。由于缺乏足够数量的供体器官，因此对于这些患者来说，循环辅助无疑是合理的选择。
